Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03692078 · ClinicalTrials.gov registry record · NA
A Study to Evaluate Changes in Smokers Using Oral Tobacco-derived Nicotine Products.
A NA study, sponsored by Altria Client Services.
- Completed
- Registry status
- NA
- Development phase
- 231
- Enrollment target
NCT03692078 is a NA study that has completed, run by Altria Client Services. The registered enrollment target is 231 participants.
The verdict
NCT03692078, a NA study, has completed, sponsored by Altria Client Services.
- COMPLETED
- Registry status
- NA
- Development phase
- 231 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate changes in exposure to selected harmful and potentially harmful constituents (HPHC) by measuring biomarkers in adult smokers who partially or completely switch from smoking cigarettes to oral tobacco-derived nicotine (OTDN) products compared to those who continue exclusive smoking cigarettes or stop using all tobacco products.
Interventions
- OTHER OTDN product 1
- OTHER OTDN product 2
- OTHER Tobacco Cessation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 231 participants |
| Start Date | 2018-05-30 |
| Est. Completion | 2018-10-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03692078
The ClinicalTrials.gov registry entry for NCT03692078 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 231 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Altria Client Services, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which OTDN product 1 is the first listed.
NCT03692078 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03692078 about?
NCT03692078 is a clinical study titled "A Study to Evaluate Changes in Smokers Using Oral Tobacco-derived Nicotine Products.". The purpose of this study is to evaluate changes in exposure to selected harmful and potentially harmful constituents (HPHC) by measuring biomarkers in adult smokers who partially or completely switch from smoking cigarettes to oral tobacco-derived nicotine (OTDN) products compared to those who cont...
What is the current status of trial NCT03692078?
This trial is currently completed. It is a NA study. The enrollment target is 231 participants. The study started on 2018-05-30. Estimated completion is 2018-10-01.
What interventions are being tested in trial NCT03692078?
The interventions under investigation include: OTDN product 1 (OTHER), OTDN product 2 (OTHER), Tobacco Cessation (OTHER).
Who is sponsoring clinical trial NCT03692078?
This trial is sponsored by Altria Client Services, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.